References

  1. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organisation classification of tumours: pathology and genetics of head and neck tumours. Lyon: International Agency for Research on Cancer (IARC). 2005; 9:430. Google Scholar

  2. Xue WQ, Qin HD, Ruan HL, Shugart YY, Jia WH. Quantitative association of tobacco smoking with the risk of nasopharyngeal carcinoma: a comprehensive meta-analysis of studies conducted between 1979 and 2011. Am J Epidemiol. 2013; 178(3):325-38. PubMed | Google Scholar

  3. Sanguineti G, Geara FB, Garden AS et al. Carcinoma of the nasopharynx treated by radiotherapy alone: determinants of local and regional control. Int J Radiat Oncol Biol Phys. 1997; 37(5):985-96. PubMed | Google Scholar

  4. Johansen LV, Mestre M, Overgaard J. Carcinoma of the nasopharynx: analysis of treatment results in 167 consecutively admitted patients. Head Neck. 1992; 14(3): 200-7. PubMed | Google Scholar

  5. Lee AW, Poon YF, Foo W et al. Retrospective analysis of 5,037 patients with naso- pharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992; 23(2):261-70. PubMed | Google Scholar

  6. Lee N, Xia P, Quivey JM et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002 May 1; 53(1):12-22. Google Scholar

  7. Pow EH, Kwong DL, McMillan AS et al. Xerostomia and quality of life after intensity-modulated radiotherapy versus conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys. 2006 Nov; 66(4):981-91. Google Scholar

  8. Al-Sarraf M, LeBlanc M, Giri PG et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099. J Clin Oncol. 1998; 16(4):1310-7. PubMed | Google Scholar

  9. Chan AT, Teo PM, Ngan RK et al. Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol. 2002; 20(8):2038-44. PubMed | Google Scholar

  10. Chan AT, Leung SF, Ngan RK et al. Overall survival after concurrent cisplatin- radiotherapy compared with radiotherapy alone in locoregionally advanced naso- pharyngeal carcinoma. J Natl Cancer Inst. 2005; 97(7):536-9. PubMed | Google Scholar

  11. Lin JC, Jan JS, Hsu CYet al. Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival. J Clin Oncol. 2003; 21(4):631-7. PubMed | Google Scholar

  12. Wee J, Tan EH, Tai BC et al. Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with american joint committee on Cancer/International union against cancer stage III and IV nasopharyngeal cancer of the endemic variety. J Clin Oncol. 2005; 23(27): 6730-8. PubMed

  13. Lee AW, Lau WH, Tung SYet al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopha- ryngeal carcinoma: NPC-9901 trial by the hong kong nasopharyngeal cancer study group. J Clin Oncol. 2005; 23(28):6966-75. PubMed | Google Scholar

  14. Lee AW, Tung SY, Ngan RK, Chappel lR, Chua DT, Lu TX et al. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902. Eur J Cancer. 2011; 47(5):656-66. PubMed | Google Scholar

  15. Dechaphunkul T, Pruegsanusak K, Sangthawan D, Sunpaweravong P. Con- current chemoradiotherapy with carboplatin followed by carboplatin and 5-fluorouracil in locally advanced nasopharyngeal carcinoma. Head Neck Oncol.2011 Juin 3; 3:30. Google Scholar

  16. Chua DT, Sham JS, Au GK et al. Concomitant chemoirradiation for stage III-IV nasopharyngeal carcinoma in chinese patients: results of a matched cohort analysis. Int J Radiat Oncol Biol Phys. 2002; 53(2):334-43. PubMed | Google Scholar

  17. Chow E, Payne D, O'Sullivan B et al. Radiotherapy alone in patients with advanced nasopharyngeal cancer: comparison with an intergroup study is combined modality treatment really necessary? Radiother Oncol.2002;63(3):269-74. PubMed | Google Scholar

  18. Zhang L, Zhao C, Ghimire B et al. The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer. 2010;10:558. PubMed | Google Scholar